​Adopted for the Kyoto-based Innovative Medical Technology Research and Development Grant Program.

MiCAN Technologies’ “Development of a novel skin sensitization test kit using iPS cell-derived human dendritic cells” has been selected for the FY2019 Kyoto-based Innovative Medical Technology Research and Development Grant Program.

For more information→